Cullen/Frost Bankers’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-8
| Closed | -$2.62K | – | 1508 |
|
2024
Q4 | $2.62K | Buy |
8
+3
| +60% | +$983 | ﹤0.01% | 1113 |
|
2024
Q3 | $1.5K | Sell |
5
-66
| -93% | -$19.8K | ﹤0.01% | 1140 |
|
2024
Q2 | $23.4K | Buy |
+71
| New | +$23.4K | ﹤0.01% | 759 |
|
2023
Q4 | – | Sell |
-191
| Closed | -$71.7K | – | 1200 |
|
2023
Q3 | $71.7K | Hold |
191
| – | – | ﹤0.01% | 662 |
|
2023
Q2 | $73.1K | Sell |
191
-14
| -7% | -$5.36K | ﹤0.01% | 669 |
|
2023
Q1 | $71K | Hold |
205
| – | – | ﹤0.01% | 666 |
|
2022
Q4 | $48.2K | Hold |
205
| – | – | ﹤0.01% | 709 |
|
2022
Q3 | $50K | Hold |
205
| – | – | ﹤0.01% | 700 |
|
2022
Q2 | $62K | Sell |
205
-15
| -7% | -$4.54K | ﹤0.01% | 669 |
|
2022
Q1 | $90K | Hold |
220
| – | – | ﹤0.01% | 641 |
|
2021
Q4 | $103K | Hold |
220
| – | – | ﹤0.01% | 633 |
|
2021
Q3 | $93K | Hold |
220
| – | – | ﹤0.01% | 639 |
|
2021
Q2 | $79K | Sell |
220
-10
| -4% | -$3.59K | ﹤0.01% | 677 |
|
2021
Q1 | $65K | Hold |
230
| – | – | ﹤0.01% | 682 |
|
2020
Q4 | $65K | Hold |
230
| – | – | ﹤0.01% | 664 |
|
2020
Q3 | $63K | Sell |
230
-60
| -21% | -$16.4K | ﹤0.01% | 629 |
|
2020
Q2 | $66K | Buy |
+290
| New | +$66K | ﹤0.01% | 612 |
|